1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Significant results from the multiple regression model with NCCT ASPECTS as dependent variable in the overall population and in late-arriving (>6 hours from LPGH) patients with AIS with LVOa
Variables Associated with ASPECTSStudy Cohort (n = 1046)Late AIS with LVO (n = 151)
Age (yr)0.02 (0.01–0.03)0.05 (0.02–0.07)
LPGH to arrival time (h)−0.11 (−0.15 to −0.08)−0.21 (−0.30 to −0.12)
Prestroke statin use0.67 (0.13–1.21)NS
Acute glucose (g/L)−0.07 (−0.13 to −0.01)NS
Hyperdense MCA sign−0.56 (−0.98 to −0.14)NS
LVOb−0.73 (−1.26 to −0.20)−
CBS0.14 (0.06–0.21)0.17 (0.03–0.31)
Good collaterals0.87 (0.51–1.23)NS
Core volume, per 10 mL−0.10 (−0.14 to −0.07)−0.21 (−0.27 to −0.15)
  • Note:—NS indicates nonsignificant; −, variable was non included in the model.
  • a Results are expressed as β coefficient and relative 95% CI.
  • ↵b Included in the predictive model for the entire study cohort only.